Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction
文献类型：期刊论文
| 作者 | Chu, Hang1; Zhang, Weitao1; Tan, Yan2; Diao, Zhipeng1; Li, Peng2; Wu, Yapeng1; Xie, Like1; Sun, Jianguo1; Yang, Ke2; Li, Pingping3,4 |
| 刊名 | JOURNAL OF ETHNOPHARMACOLOGY
 |
| 出版日期 | 2023-12-05 |
| 卷号 | 317页码:14 |
| 关键词 | Fibrosis Inflammation Lipogenesis NASH QZTGT TMNP |
| ISSN号 | 0378-8741 |
| DOI | 10.1016/j.jep.2023.116665 |
| 通讯作者 | Hua, Qian(huaq@bucm.edu.cn) ; Xu, Xiaojun(xiaojunxu2000@163.com) |
| 英文摘要 | Ethnopharmacological relevance: Qing-Zhi-Tiao-Gan-Tang or Qing-Zhi-Tiao-Gan Decoction (QZTGT) is based on the compatibility theory of traditional Chinese medicine (TCM), that is a combination of three classical formulae for the treatment of nonalcoholic fatty liver disease (NAFLD). Its pharmacodynamic material basis is made up of quinones, flavanones, and terpenoids.Aim of the study: This study aimed to look for a promising recipe for treating nonalcoholic steatohepatitis (NASH), a more advanced form of NAFLD, and to use a transcriptome-based multi-scale network pharmacological platform (TMNP) to find its therapy targets. Materials and methods: A classical dietary model of NASH was established using MCD (Methionine-and cholinedeficient) diet-fed mice. Liver coefficients like ALT, AST, serum TC, and TG levels were tested following QZTGT administration. A transcriptome-based multi-scale network pharmacological platform (TMNP) was used to further analyze the liver gene expression profile.Results: The composition of QZTGT was analyzed by HPLC-Q-TOF/MS, a total of 89 compounds were separated and detected and 31 of them were found in rat plasma. QZTGT improved liver morphology, inflammation and fibrosis in a classical NASH model. Transcriptomic analysis of liver samples from NASH animal model revealed that QZTGT was able to correct gene expression. We used transcriptome-based multi-scale network pharmacological platform (TMNP) to predicted molecular pathways regulated by QZTGT to improve NASH. Further validation indicated that "fatty acid degradation", "bile secretion" and "steroid biosynthesis" pathways were involved in the improvement of NASH phenotype by QZTGT.Conclusions: Using HPLC-Q-TOF/MS, the compound composition of QZTGT, a Traditional Chinese prescription, was separated, analyzed and identified systematically. QZTGT mitigated NASH symptoms in a classical dietary model of NASH. Transcriptomic and network pharmacology analysis predicted the potential QZTGT regulated pathways. These pathways could be used as therapeutic targets for NASH. |
| WOS关键词 | DIET |
| 资助项目 | National Natural Science Foundation of China[82273990] ; National Natural Science Foundation of China[U21A20414] ; National Science amp; Technology Major Project Key New Drug Creation and Manufacturing Program, China[2019ZX09201001-001-001] ; CAMS Innovation Fund for Medical Sciences[2016-I2M-4-001] ; Beijing Outstanding Young Scientist Program[BJJWZYJH01201910023028] ; Chinese Academy of Medical Sciences (CAMS) Central Public-interest Scientific Institution Basal Research Fund[2018RC350004] ; Chinese Academy of Medical Sciences (CAMS) Central Public-interest Scientific Institution Basal Research Fund[2017PT31046] ; Open Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University[SKLNMKF202208] |
| WOS研究方向 | Plant Sciences ; Pharmacology & Pharmacy ; Integrative & Complementary Medicine |
| 语种 | 英语 |
| WOS记录号 | WOS:001038102000001 |
| 出版者 | ELSEVIER IRELAND LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/306749]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Hua, Qian; Xu, Xiaojun |
| 作者单位 | 1.China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China 2.Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China 3.Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China 4.Chinese Acad Med Sci, Diabet Res Ctr, Beijing 100050, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chu, Hang,Zhang, Weitao,Tan, Yan,et al. Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction[J]. JOURNAL OF ETHNOPHARMACOLOGY,2023,317:14. |
| APA | Chu, Hang.,Zhang, Weitao.,Tan, Yan.,Diao, Zhipeng.,Li, Peng.,...&Xu, Xiaojun.(2023).Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction.JOURNAL OF ETHNOPHARMACOLOGY,317,14. |
| MLA | Chu, Hang,et al."Qing-Zhi-Tiao-Gan-Tang (QZTGT) prevents nonalcoholic steatohepatitis (NASH) by expression pattern correction".JOURNAL OF ETHNOPHARMACOLOGY 317(2023):14. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。